HVHeather A. PhD Vitko

Heather A. PhD Vitko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Heather A. PhD Vitko has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Probiotics for Infection Prevention in Critically Ill and Trauma Patients: A Concise Review

    by Heather A. PhD Vitko, Jordan J. Crnp Troxell, Paula R. PhD Sherwood

    BACKGROUND: Critically ill trauma patients are at an increased risk for infection, which can increase morbidity and mortality. The use of probiotic preparations for infection prevention is promising, yet the results of their effectiveness are mixed. OBJECTIVES: To synthesize current research regarding the use of probiotics to prevent and possibly treat infection in the critically ill adult trauma population. METHODS: DATA SOURCES: The medicine and nursing databases PubMed, CINAHL, and ProQuest were searched for this review. STUDY SELECTION: Studies addressed the efficacy of probiotics in the critically ill in reducing health care–associated infection rates, with particular emphasis on patients who experienced severe trauma. DATA EXTRACTION: Studies were reviewed and included through the consensus of the authors. Each study's population, design, methodology, results, and conclusions were analyzed for relevance. Of 170 publications retrieved and reviewed, 21 articles were identified for use in this review, including original research, meta-analyses, and reviews. RESULTS: DATA SYNTHESIS: There is a lack of homogeneity of studies concerning probiotic species/strain selection and frequency and timing of dosing in the current body of literature. KEY THEMES: There is also a lack of consensus on what constitutes a “health care–associated infection,” with few studies identifying specific types of infection and the role probiotics may play in preventing these infections. CONCLUSION: Upon reviewing the current body of evidence, one cannot definitively conclude that probiotic supplementation in the critically-ill trauma population decreases health care–associated infection rates and improves outcomes, but most published evidence supports their use.


  • Open Access

    Probiotics in the critical care unit: fad, fact, or fiction?

    by Heather A. Vitko, Jordan J. Troxell

    Thegut microbiome consists of normally non-pathogenic bacteria, viruses, andfungi. These friendly microbes serve to maintain gastrointestinal (GI) barrierfunction and integrity, play a role in host nutrient and drug metabolism,immunomodulation, and prevent pathogenic bacteria from colonizing or causingdisease. Healthy people have used probiotics for centuries to promote andrestore GI health by restoring the normal flora. Probiotics continue tocaptivate consumers in the current health conscious society for theirprovocative health claims. The importance of a healthy microbiome for theoverall health of the host is just recently being appreciated within themedical and science communities, however. Disruption of the microbiome placesone at greater risk for illness and infection. Critically ill patients areamong those at highest risk for complications associated with microbialimbalance, or dysbiosis. Patients being cared for in intensive care units aresubjected to a variety of treatments and therapies that account for a tendencytoward dysbiosis. These include treatment with antibiotics, proton pumpinhibitors, and opioids as well as therapies that require invasive proceduresand monitoring. With the consequential compromise to one’s immunity, criticallyill patients are at the greatest risk for healthcare-associated infections(HAIs). One suggested means to restore immune function and for the preventionof HAIs is to supplement patients with probiotics. Probiotics may serve toprevent and ameliorate the effects of a number of HAIs, including: ventilator-associatedpneumonia (VAP), Clostridium difficile infection (CDI),catheter-associated urinary tract infection (CAUTI), and surgical-siteinfection (SSI). Despite promising findings regarding the efficacy ofprobiotics for a number of conditions, supplementation with probiotics is notwithout risks. Consumers and prescribers must be educated on what probioticscan and cannot do and should understand that not all probiotics are the same.